FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 31 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $6,458,000 | -22.6% | 1,040,000 | -7.1% | 0.10% | -25.0% |
Q4 2020 | $8,344,000 | +22.9% | 1,120,000 | 0.0% | 0.13% | -3.8% |
Q3 2020 | $6,787,000 | -27.4% | 1,120,000 | 0.0% | 0.13% | -34.5% |
Q2 2020 | $9,352,000 | +118.7% | 1,120,000 | +55.6% | 0.20% | +46.0% |
Q1 2020 | $4,277,000 | -8.3% | 720,000 | 0.0% | 0.14% | +6.1% |
Q4 2019 | $4,666,000 | +34.7% | 720,000 | 0.0% | 0.13% | +14.9% |
Q3 2019 | $3,463,000 | +20.2% | 720,000 | 0.0% | 0.11% | +29.5% |
Q2 2019 | $2,880,000 | -17.5% | 720,000 | 0.0% | 0.09% | -26.7% |
Q1 2019 | $3,492,000 | -24.0% | 720,000 | 0.0% | 0.12% | -40.9% |
Q4 2018 | $4,594,000 | -24.4% | 720,000 | -2.9% | 0.20% | -9.0% |
Q3 2018 | $6,078,000 | -21.5% | 741,175 | 0.0% | 0.22% | -30.5% |
Q2 2018 | $7,738,000 | -13.6% | 741,175 | 0.0% | 0.32% | -23.6% |
Q1 2018 | $8,961,000 | +21.3% | 741,175 | 0.0% | 0.42% | +9.1% |
Q4 2017 | $7,390,000 | – | 741,175 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |